Grants.gov · synopsis:posted
DoW Neurofibromatosis Exploration-Hypothesis Development Award
- Verified from source 1 day ago
- Updated 24 days ago
- Amendment detected
- Agency
- Defense Health Agency Contracting Activity - DHACA
- Office
- DOD-AMRAA
- Type
- synopsis:posted
- Kind
- grant
- Posted
- Jun 25, 2026
- Place
- —
- Notice ID
- 362976
- Source
- Grants.gov
- First seen
- Sep 18, 2026, 1:21 PM UTC
Full scope
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Description
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Distinctive Features:
• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.
• Preliminary Data: Preliminary and/or published data is encouraged but not required.
Documents
- HT042526NFRPEHDA_GG.pdf FY26 NFRP EHDA Program Announcement Grants.gov access required
Contacts
-
Ebony S Simmons Grantor
Related links
Full record synced 7 days ago from Grants.gov